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Abstract The ability of neutrophils and other leucocyte
members of the innate immune system to expel their DNA
into the extracellular environment in a controlled manner in
order to trap and kill pathogenic microorganisms lead to a
paradigm shift in our understanding of host microbe inter-
actions. Surprisingly, the neutrophil extracellular trap (NET)
cast by neutrophils is very wide and extends to the entrap-
ment of viruses as well as multicellular eukaryotic parasites.
Not unexpectedly, it has emerged that pathogenic microor-
ganisms can employ a wide array of strategies to avoid
ensnarement, including expression of DNAse enzymes that
destroy the lattice backbone of NETs. Alternatively, they
may use molecular mimicry to avoid detection or trigger
events leading to the expression of immune modulatory
cytokines such as IL-10, which dampen the NETotic re-
sponse of neutrophils. In addition, the host microenviron-
ment may contribute to the innate immune response by the
production of lectin-like molecules that bind to bacteria and
promote their entrapment on NETs. An example of this is
the production of surfactant protein D by the lung epitheli-
um. In addition, pregnancy provides a different challenge, as
the mother needs to mount an effective response against
pathogens, without harming her unborn child. An examina-
tion of these decoy and host response mechanisms may open
the path for new therapies to treat pathologies mediated by
overt NETosis.
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Introduction
Neutrophil granulocytes, also frequently termed polymor-
phonuclear neutrophils (PMN), are the most abundant mem-
bers of the leucocyte population, comprising between 50
and 70 % of total white blood cells in normal healthy in-
dividuals [1, 2]. PMNs are a vital component of the innate
immune system and form the first line of defense against
invading pathogenic microorganisms [1, 2]. Traditionally,
this interaction has been considered to involve phagocytosis
and lytic destruction of pathogens by toxic neutrophil gran-
ular proteins and reactive oxygen species (ROS) in the
phagolysosome or the release of these agents directly into
the extracellular environment by degranulation [1, 2].
This paradigm was altered by the discovery that PMNs
could release their genomic DNA into the extracellular
environment in the form of neutrophil extracellular traps
(NETs) that could ensnare invading microorganisms [3].
Analysis of these novel NET structures showed that they
were decorated by proteins from all three PMN granule
groups (azurophilic, secondary, and tertiary), including neu-
trophil elastase (NE), myeloperoxidase (MPO), lactoferrin,
and gelatinase [3]. It was proposed that by being tightly
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associated with the DNA lattice structure of NETs, the
presence of bactericidal granular proteins in these molecular
traps would be able to kill pathogenic invaders in a highly
efficient manner with minimal damage to the surrounding
tissue [3].
In the interim, it has emerged that the interaction between
hostile microorganisms and neutrophil NETs is more com-
plex than originally thought. In this review, we will high-
light some of these developments.
Interaction with bacteria and fungi
In their seminal publication, Brinkmann et al. demonstrated
that NETs could be induced by both Gram-positive (Staph-
ylococcus aureus) and Gram-negative (Salmonella
typhimurium and Shigella flexneri) bacteria and displayed
signs of incapacitating the virulence of these agents by the
action of NET-associated extracellular proteases [3].
This finding was rapidly extended to show that neutro-
phil NETs could also be induced by eukaryotic pathogens
such as the ascomycetous yeast, Candida albicans [4]. In
this study, it was demonstrated that NETs interact both with
the single cell yeast form as well as the multicellular hyphal
form and incapacitate these via action of granular compo-
nents. The generation of NETs was more pronounced in
cases in which the yeast cells, either yeast or hyphal form,
were opsonized. Opsonization was, however, not a prereq-
uisite for NETosis.
The fungicidal activity of NETs was subsequently shown
to be largely due to the presence of calprotectin, an antimi-
crobial heterodimer with calcium- and zinc-binding proper-
ties [5]. The absence of calprotectin in S100A9 knockout
mice rendered these animals highly susceptible to infections
with C. albicans.
Evidence that NETs may play a role in the human innate
immune response was provided by patients with chronic
granulomatous disease (CGD) [6]. In such patients,
NETosisis abrogated due to a deficiency in the nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase genes
that prevent efficient ROS generation. This genetic deficien-
cy renders this patient group particularly prone to pulmo-
nary infections with Aspergillus fungi.
To correct for this deficiency, a gene therapy approach
was investigated by which the defective gp91phox gene was
replaced by a functional gene encoded from a retroviral
vector. By this means, it was possible to cure a child from
refractory aspergillosis and to enable a return to a normal
life free from the restrictions of sterile confinement [6].
Although functional NADPH oxidase was detectable in only
16 % of PMN for a period of 3 months postgene therapy,
this low level was sufficient for efficient clearing of the
fungal infection. Furthermore, in in vitro examinations of
the gene-modified cells, it was demonstrated that they
underwent NETosis following interaction with A. nidulans
isolated from the patient’s lungs and that such NETs effec-
tively inhibited fungal growth.
Direct real-time in vivo evidence of the interaction be-
tween neutrophil NETs and invading fungal pathogens was
obtained in murine lungs using two-photon microscopy [7].
In this study, it was shown that neutrophils generate NETs in
response to interaction with both Aspergillus fumigatus
morphotypes, namely conidia and hyphae. NETs detected
in the lungs of infected animals formed with rapid kinetics,
occurring within 3–4 h of PMN exposure to the fungi. A
discrepant finding of this study was that NETs did not
appear to be the major contributor to the killing of A.
fumigatus, unlike what was previously clearly demonstrated
to be the case for C. albicans, but may, in this instance,
contribute to fungal demise by binding of secreted proteins
or membrane structures and thereby preventing fungal
spread.
Mechanisms to evade NET entrapment by bacteria
or fungi
Similar to “spy vs. spy” scenarios, it is obvious that in
biology, attacker and evader will develop different strategies
to counteract each other. In the case of NETs, several sys-
tems appear to be employed by bacteria or fungi to render
them ineffective. Not unexpectedly, these strategies rely on
the use of nucleases that attack the DNA backbone of the
NET lattice structure [8, 9].
The first report of such an evasive strategy was made in
strains of Group A streptococcus, which, by the expression
of a DNAse molecule Sda1, were determined to be more
virulent than strains lacking this enzyme. In addition, the
inhibition of this enzyme reduced infectivity and promoted
clearance by PMN [10] (Fig. 1a).
In a similar manner, endonuclease expression by Strep-
tococcus pneumoniae [11] or S. aureus [12] was shown to
permit these organisms to evade ensnarement by NETs,
thereby boosting their virulence (Fig. 1a). Consequently,
these nucleases are currently being evaluated as targets for
novel antibacterial therapies [13].
Recently, evidence of more complex evasive strategies
employing elements of molecular mimicry has emerged. In
the instance of Pseudomonas aeruginosa, it appears that this
opportunistic pathogen exploits the acquisition of sialic acid
motifs form host cells [14]. Sialic acids, also termed Sias,
are unusual monosaccharides characterized by a shared
nine-carbon backbone [15]. They are widely expressed on
the cell surface of most mammalian cells. In order to evade
detection and destruction by the host immune system, a
number of bacteria have been shown to acquire and coat
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themselves with host Sias [16]. In this manner, such patho-
gens will not only immunologically appear as “self” rather
than as “foreign,” but by binding to specific Sias, lectin-like
receptors (siglecs) on host cells dampen the host immune
response against them [16].
By absorbing host serum Sias, P. aeruginosa was able to
bind directly to PMN via siglec-9 and, thereby, stimulate the
production of the potent immune-modulating cytokines IL-
10 and TGF-β. Furthermore, this interaction attenuated the
generation of ROS and the release of neutrophil elastase
(NE) by PMN engaged in this manner. Since the generation
of ROS is a pivotal step required for NETosis, it comes as no
surprise that PMN exhibited a reduced ability to generate
NETs when confronted with Sias-coated P. aeruginosa bac-
teria [14] (Fig. 1b). It is not clear if the IL-10 present in this
system is produced by neutrophils or by bystander cells, as it
has been suggested that human neutrophils have an inactive
IL-10 gene locus [17].
Fungi have also developed analogous evasive counter-
measure. In the interaction between PMN and with Asper-
gillus species, it was determined that the presence of the
hydrophobin RodA protein on the cell surface of conidia
leads to a reduction in NETosis [7]. The presence of this
hydrophobic protein that coats resting conidia, but not hy-
phae, has previously been shown to largely negate an anti-
fungal innate immune response [7] (Fig. 1b). A summary of
the reported mechanisms of pathogen evasion from NETs is
given in Table 1.
Tuberculosis: interaction between macrophages and
neutrophils
The elimination of invasive pathogenic microorganisms
involves a delicately orchestrated interplay between
them and among members of the innate and the adap-
tive immune systems [18, 19]. A prime example of this
system breaking down, permitting the virulent bacterium
to thrive and eventually kill the host, is provided by
Mycobacterium tuberculosis [20].
Even though the tubercle bacillus was described by
Robert Koch back in 1882, tuberculosis (TB) remains a
leading cause of worldwide mortality (1.4 million deaths
in 2011) and morbidity (8.7 million new infections in 2011),
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Fig. 1 Mechanisms of defense against bacteria and fungi and strate-
gies of evasion of NET entrapment. NETs can be induced by both
Gram-positive or Gram-negative bacteria (a). Evasion of the antimi-
crobial activity of NETs may include the use of nucleases that attack
the DNA backbone of the NETs' lattice structure (a) or elements of
molecular mimicry that stimulate the production of the potent immune-
modulating cytokines (b). NE neutrophil elastase, PMN polymorpho-
nuclear neutrophil, MPO myeloperoxidase, LL37 cathelicidin, CG
cathepsin G, IL10 interleukin 10, TGFβ transforming growth factor
beta
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second only to human immunodeficiency virus (HIV)
[20]. Despite this large health care burden, surprisingly little
has been undertaken to investigate the potential role of neutro-
phils or their NETs in combating this insidious infection [21].
This may be largely due to the intrinsic properties of PMN,
in that they are short lived and cannot be cryopreserved, neces-
sitating the constant use of fresh primary cells, which restrict
their availability and utilization [21]. Furthermore, macrophages
are considered to be the prime target of this bacterium and
to be crucial for its removal and containment in granulomas.
Nonetheless, the role played by PMNs in the initial
combating and subsequent harboring of the M. tuberculosis
bacilli is gaining recognition, since a large influx of PMNs
is evident at the site of infection and PMNs may account for
the predominant phagocytic cells infected by M. tuberculo-
sis bacilli [22]. In addition, a transcriptomic analysis of
human blood samples from TB patients suggests that tuber-
culosis is associated with a neutrophil-driven interferon-
induced profile [23]. Furthermore, PMNs are required for
granuloma formation in chronic infection. Experiments in
mice suggest that the recruitment of PMNs to the site of
infection reduces the number of infective M. tuberculosis
bacilli from the lungs and prevents their spread to secondary
organs, such as the spleen [21]. This is consistent with
reports in humans, where the risk of infection is inversely
proportional to peripheral PMN cell counts [21].
That M. tuberculosis bacilli induce NETosis has become
evident from the study by Ramos-Kichik et al. [24]. In
examining the influence of two strains of M. tuberculosis
with high or low (M. tuberculosis H37Rv and M. canetti)
virulence on isolated PMNs in vitro, it was observed that
both strains lead to the formation of leucocyte clusters or
aggregates [24]. Remarkably, both M. tuberculosis strains
induced the formation of neutrophil NETs, as detected by
scanning and transmission electron microscopy. This feature
was confirmed by fluorescence immunohistochemical
staining for DNA, histones, and neutrophil elastase [24].
NETosis was found to be associated with the demise of
PMNs and the release of intracellular constituents (LDH),
as originally reported by Brinkmann et al. [3]. No significant
difference in the degree of NETosis induction by either the
virulent N37Rv or the nonvirulent M. canetti strains could
be discerned. Of particular interest was the observation that,
although the PMN NETs were induced by M. tuberculosis
bacilli and could ensnare these microorganisms, they were
incapable of killing these bacilli. This was in strong contrast
to what was observed in the case of Listeria monocytogenes
under the same conditions, in which the entrapment by
NETs lead to a significant reduction in bacterial survival
and infectivity. This effect was not due to the M. tuberculosis
bacilli rendering the NETs inert, as the addition of such NETs
to L. monocytogenes cultures was capable of killing the latter.
This effect was abolished if the DNA lattice of the NETs was
destroyed by addition of nuclease. Consequently, the inability
of NETs to kill M. tuberculosis bacilli must be a reflection
upon the unique nature of the cell wall of these bacilli, its high
lipid content rendering them impervious to the action of
immune cell attack, be it by PMNs or macrophages.
Table 1 Strategies of NET evasion by various pathogens
Pathogen Mediator Mechanism of action Refs.
Group A Streptococci Sda1 NET degradation [8–10]
Streptokinase Fibrinolysis [76, 77]
Streptococcus pneumoniae Endonuclease NET degradation [11]
Staphylococcus aureus Endonucleases NET degradation [12, 13]
Staphylocoagulase NET degradation [78, 79]
vWF-binding protein Exploitation of coagulation [78, 79]
CLFA and CLFB Platelet aggregation [74]
Pseudomonas aeruginosa Sialic acid Molecular mimicry [14, 16]
Aspergillus fumigatus, A. nidulans RodA Molecular mimicry [7]
Mycobacterium tuberculosis H37Rv High lipid cell wall content Molecular mimicry [19, 23]
Mycobacterium canetti High lipid cell wall content Molecular mimicry [23]
Mycobacterium bovis BCG Mφ-ingested PMN CG and NE Modulation of NETosis [25, 26]
Mycobacterium smegmatis Microparticles and ectosomes Modulation of NETosis [27, 28]
IFNγ and ESX-1 system Modulation of NETosis [29]
Leishmania amazonensis Coinfection with FeLV Modulation of NETosis [84]
Human immmunodeficiency virus CD209 binding Modulation of NETosis [86, 87]
NET neutrophil extracellular trap, vWF von Willebrand factor, CLFA clumping factor A, CLFB clumping factor B, RodA hydrophobin RodA
protein, BCG bacillus Calmette-Guérin, Mφ macrophage, PMN polymorphonuclear neutrophil, CG cathepsin-G, NE neutrophil elastase, IFNγ
interferon gamma, ESX-1 mycobacterial ESX-1 secretion system, FeLV feline leukemia virus
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The interplay betweenM. tuberculosis bacilli and members
of the innate immune system may, however, be more complex
than previously thought, a change in concept supported by a
spate of recent publications [18, 19, 25]. In this context, it has
been observed that macrophages are able to ingest neutrophil
azurophil granular proteins and use them to kill invasive
mycobacteria [26, 27]. In the first of these reports, Steinwede
et al. examined the role of cathepsin G (CG) and neutrophil
elastase (NE) in the alveolar clearance of mycobacterial in-
fections, in particular M. bovis bacillus Calmette-Guérin (M.
bovis-BCG). They observed that genetically altered knockout
mice for CG, and especially CG/NE, exhibited a reduced
capacity for clearing bacterial infections, resulting in increased
bronchoalveolar pathology. This could be overcome by aero-
sol therapy with CG/NE-loaded liposomes. Of interest is that
these enzymes were taken up by alveolar macrophages and
used by these to expedite bacterial elimination.
In a subsequent study, Jena et al. observed that macro-
phages can endocytose neutrophil-derived azurophilic en-
zymes and employ these for bacillus destruction [27]. They
included M. smegmatis, M. bovis-BCG as well as the viru-
lent M. tuberculosis H37Rv strain. Their data indicate that
the acquisition of azurophilic enzymes and their presence
within macrophages leads to the disintegration of the bacte-
rial cell membrane and to bacterial cell lysis (Fig. 2).
As these two studies report on very similar phenomena,
this would suggest that the uptake of PMN-derived granules
by macrophages could be a relatively common cooperative
mechanism utilized by the innate immune system to elimi-
nate certain bacteria. It also opens a potential pathway for
novel therapeutic strategies.
Such cooperation may include other factors such as mi-
croparticles (MP) released by infected macrophages or
PMN. In the instance of macrophage-derived MPs, these
appear to be proinflammatory and attract PMN and other
immune effector cells to sites of application [28]. These
MPs were shown to contain mycobacterial antigens and
promote specific CD4+ T cell activation both in vitro and
in vivo. In contrast to these proinflammatory observations, it
has been suggested that ectosomes derived from M. tuber-
culosis bacilli-infected PMN reduced the antimycobacterial
activity of accessory macrophages [29]. Clearly, these dis-
parities will need to be resolved.
A very intriguing recent observation in this context was
made by Wong and Jacobs, in which they report on the
generation of ETs (extracellular traps) by macrophages heavi-
ly infected with M. tuberculosis bacilli [30]. This effect was
dependent on the presence of IFN-γ and the mycobacterial
ESX-1 system, which mediated phagosomal rupture and sub-
sequent bacterial escape. The macrophage ETs were deter-
mined to be remarkably similar to neutrophil NETs by having
a DNA backbone readily destroyed by DNAse action and the
occurrence of citrullinated histones. Furthermore, akin to the
neutrophil NETotic process, the generation of macrophage
ETs was also dependent on an elastase activity, as the process
could be blocked by treatment with an elastase inhibitor,
AAPV. The ability to generate traps was strongly dependent
on whether the primary human macrophages had been differ-
entiated with the aid of G-CSF but not GM-CSF. In addition,
priming with IFN-γ was an essential requirement for ET
triggering byM. tuberculosis bacilli. This feature was observ-
able both under physiological oxygen tensions (5–10 %) as
well as under normal tissue culture conditions (20 %).
The triggering of ETs by M. tuberculosis bacilli was
strongly dependent on the bacteria possessing an intact
ESX-1 system. It has previously been shown that the ex-
pression of these factors leads to caspase-1-independent cell
death of infected macrophages. ESX-1 also leads to the
activation of the inflammasome and release of IL-1 beta
[31]. The role of this proinflammatory cytokine in macro-
phage ETosis is currently unclear.
On the other hand, the action of IFN-γ appears to pro-
mote the aggregation of M. tuberculosis bacilli in macro-
phages, thereby providing the necessary impetus for ETosis.
This action was also accompanied by widespread necrosis
of infected macrophages. It, therefore, appears that the ESX-
1 system subverts the action of IFN-γ to enhance or amplify
M  
NETing PMN 
M. tuberculosis 
M. canetti 
M. smegmatis 
M. bovis 
Azurophil granule proteins 
M  
METing M  
ESX-1 
IFNγ  
Fig. 2 Neutrophils and macrophages cooperate in order to confront
mycobacterial infections.Mycobacterium bacilli induce leucocyte clus-
tering or aggregation and, subsequently, NETosis, but not killing of
these pathogens. Macrophages are able to ingest neutrophil azurophil
granular proteins and dispatch invasive mycobacteria. The generation
of ETs (extracellular traps) by macrophages is dependent on the pres-
ence of IFN-γ and the mycobacterial ESX-1 system, which mediate
phagosomal rupture and subsequent bacterial escape
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the aggregation of bacilli, macrophage ETosis, and necrosis
(Fig. 2).
Role of cathelicidin in combating microorganisms
Antimicrobial peptides play a fundamental role in the pro-
tection against microbial attack in a number of systems,
evident by their widespread distribution throughout the an-
imal and plant kingdoms [32]. In humans, two major fam-
ilies of antimicrobial peptides have been identified as
defensins and cathelicidin. Cathelicidin family of antimicro-
bial polypeptides are characterized by a highly conserved
region (cathelin domain) and a highly variable cathelicidin
peptide domain [33]. Human Cathelicidin(LL-37) is a cat-
ionic, host defense peptide, mainly expressed by neutrophils
and epithelial cells during acute inflammation. LL-37 cor-
responds to amino acid 134–170 of Human cationic Anti-
microbial Protein 18 (hCAP-18), which is present in specific
granules of human neutrophils and produced after the C
terminal cleavage of hCAP 18 by caspase 3 [34].
LL-37 is known to exhibit broad-spectrum antimicrobial
activity against a wide range of Gram-positive and Gram-
negative bacteria species [35–37], including tuberculosis, where
in combination with lipocalin 2, it restricts the growth of this
microorganism in an iron-dependent manner [38]. It also ex-
hibits inhibitory activity against certain fungi and enveloped
viruses [39]. This capability can be transferred to other species,
including plants, as demonstrated by a recent experiment in
which expression of LL-37 in transgenic plants lead to resis-
tance to bacterial and fungal pathogens [40]. The mechanism of
bacterial killing by LL-37 is rapid and mostly involves interca-
lation and assembly of peptides within the bacterial membrane
to disrupt membrane integrity [41]. By the use of time-lapse
fluorescence microscopy, it was shown that LL-37 adopted
alternate mechanisms for membrane disruption depending upon
the concentration of the peptide [42]. In addition to antimicro-
bial activity, LL-37 has been shown to be associatedwith awide
range of biological activities including the inhibition of biofilm
formation, chemotaxis andmast cell degranulation, induction of
chemokines, enhancement of keratinocyte migration and pro-
liferation, and enhancement of vascularization [43, 44].
Inappropriate activity by LL-37 can lead to considerable
tissue damage, especially in infections of the respiratory
tract by pathogens such as S. aureus, which can lead to
excessive fibrinolysis [45]. In addition, aberrant expression
of cathelicidin has been linked to increased susceptibility to
skin infections, frequent oral bacterial infections, severe
periodontal disease, and cutaneous infections [46]. For ex-
ample, histological examination of a number of chronic
inflammatory skin diseases such as atopic dermatitis, rosa-
cea, and psoriasis have shown that the proinflammatory
peptide is dysregulated in these disorders [39].
This facet may be due to an unexpected interaction be-
tween LL-37 and extracellular host DNA derived from dying
cells [47, 48]. In these studies, it was shown that LL-37 binds
very stably to DNA and then acts as a transfecting agent,
dragging this macromolecular complex into adjacent cells,
where it can interact with toll-like pattern recognition recep-
tors. In psoriasis, these bystander cells happen to be
plasmacytoid dendritic cells (pDCs), which can elicit a potent
immune response via the production of interferons [47].
Since cathelicidin is intimately associated with NETs, its
presence may contribute to inflammatory conditions associ-
ated with aberrant NETosis such as occurs in autoantibody
(ANCA) small vessel vasculitis [49]. This may involve
further autoinflammatory conditions such as rheumatoid
arthritis [50].
Although LL-37 constitutes a formidable innate immuni-
ty defense barrier against infections, some bacterial species
have developed various mechanisms to circumvent its ac-
tion. An example is the oral pathogen Porphyromonas
gingivalis associated with chronic periodontal disease,
which can degrade LL-37 by utilizing its arginine-specific
gingipains enzyme [51]. In addition, S. aureus can cleave
and inactivate LL-37 by the action of its metalloproteinase
called “aureolysin,” in a time- and concentration-dependent
manner [52]. Analogously, M1 protein promotes the surviv-
al of Group A streptococcus through the inhibition of
cathelicidin [53]. On the other hand, the action of
cathelicidin may be affected by pathological conditions such
as cystic fibrosis, where its interaction with glycosamino-
glycans can inhibit its antimicrobial activity, a facet that can
be restored by treatment with hypertonic saline [54].
LL-37 may also influence neutrophil behavior, inducing
secondary necrosis in these cells, leading to the release of
IL-8, IL-1R antagonist, and granules [55]. Furthermore, LL-
37 seemed to enhance the production of IL-8 and ROS
production. It is currently unclear if such action by LL-37
leads to the induction of NETosis. Apart from powerful
chemotactic activities, which appear to be, in part, mediated
via interaction with the formyl peptide receptors [56], LL-37
can also promote monocyte adhesion, thereby illustrating a
new mode of neutrophil interaction with these cells [57].
The induction of IL-8 by LL-37 may be pivotal in the
combat of respiratory infections. Of particular interest is that
this is not restricted to neutrophils but may include airway
smooth muscle cells [58].
Role of immunothrombosis in combating microbial
infections
In a recent review by Engelmann and Massberg [59], recapit-
ulating the recent progress in the field of hemostasis and
thrombosis activated by circulating microorganisms, the
444 Semin Immunopathol (2013) 35:439–453
concept of immunothrombosis was coined. Immunothrombosis
is defined as an innate immune response led by specific cells
and molecules, which interact to form thrombi inside the blood
vessels. When uncontrolled, it represents a major biological
process fostering thrombosis-associated pathologies.
NETs appear to play a central role in immunothrombosis,
supporting the above-described process through several
means. NETs can directly activate factor XII (the contact
pathway of coagulation), probably due to their electrochemi-
cal properties [60]. It has been shown that NETs bind directly
to von Willebrand factor (vWF) and enhance the process of
platelet recruitment [61]. Moreover, histones H3 and H4,
present in the NETs, can trigger the activation of platelets
[62] and stimulate platelet adhesion [63]. Other indispensable
components of NETs, such as the proteolytic antimicrobial
enzymes NE and MPO, can actively regulate the clotting
cascade, on the one hand, by cleaving or oxidizing major
natural anticoagulant substances, including tissue factor path-
way inhibitor (TFPI) [64] and thrombomodulin [65], which
propagates coagulation. On the other hand, in vitro studies
have shown that the aforementioned proteases can also de-
grade fibrin [66], and since they are present on NETs, they
could be potentially involved in the resolution of the clots [67,
68]. In all cases, treatment with DNase1 prevents thrombus
formation, underscoring the importance of NETs for the pro-
cess. Additionally, NETs can bind to TF and promote the
activation of the extrinsic pathway of coagulation [69]. In
vitro, NETs stimulate fibrin formation and deposition, and
fibrin colocalizes with NETs in blood clots [67, 70].
In this context, the engaged neutrophils and monocytes
are most probably stimulated by activated platelets via PRRs
in order to form NETs [60, 71]. In turn, activated platelets
not only stimulate NET formation but also the NETs that are
generated trigger de novo platelet activation, red cell accu-
mulation, and thrombosis [72, 73].
In the framework of the organism's defense tactics against
pathogens, immunothrombosis is thought to perform a broad
series of physiological functions. First, it facilitates capture
and tanglement of blood-borne pathogens, limiting their
spread by retaining the microorganisms within the fibrin clot.
In this way, tissue invasion by pathogens is prevented through
microthrombus formation [68]. Further, these intravascular
clots generate a separate compartment that focuses all antimi-
crobial strategies to distinct loci favoring pathogen killing.
This involves both innate immune cells and the antimicrobial
substances generated during their activation [74, 75]. Finally,
fibrinogen or fibrin accumulation and deposition in the small
vessels enhances the additional recruitment of reactive cells to
the damaged site of tissue infection, supporting the pathogen
recognition and directing the immune response [76]. The basic
features of immunothrombosis are depicted in Fig. 3.
The broad range of sophisticated strategies that patho-
genic microorganisms have evolved in in order to subvert,
additionally, immunothrombosis, apart from the herein de-
scribed NETosis, underlines the crucial role of this process
against their propagation [75, 77–80]. These strategies are
also summarized in Table 1.
Viral interactions with neutrophil NETs
The interaction of neutrophils and viruses is less well char-
acterized than those with bacteria or fungi, especially with
regard to NETosis. Indeed, it was unclear if PMN NETs
were beneficial or detrimental in cases of viral infections, as
PMNs have been associated with increased pulmonary dam-
age in murine influenza model systems [81–83].
This enigma was clearly addressed in a recent publication
within travital microscopy to track the murine PMN re-
sponse to infection with an oncolytic poxvirus in vivo
[84]. In their experiments, the authors determined that
PMN were recruited to the liver following administration
with poly I:C (polyinosinic:poliycitidylic acid), a double-
strand nucleotide viral analog, lypopolysaccheride (LPS), or
challenge with the pox virus [84]. The activation of PMNs by
poly I:C or pox virus involved toll-like receptor 3 (TLR3) of
the innate immune pattern recognition receptors (PRR). This
treatment increased the expression of the cell surface integrin
molecule CD11b, which facilitates attachment of PMN on host
endothelium. Furthermore, viral challenge induced thrombo-
cytopenia, platelet accumulation in the liver, and generation of
PMN NETs. In this manner, it is possible that infection with
pox virus mobilizes an immune–thrombotic response [59],
which would serve to immobilize the virus for efficient clear-
ance by macrophages. The generation of NETs appears to be
useful in the clearance of virus, as their induction by LPS
treatment promoted viral clearance, whereas their dissolution
by DNAse treatment facilitated viral persistence [84].
Viral modulation of NETosis: feline leukemia virus
Viral infections appear to be able to modulate the host
NETotic response. The first indication of such an occurrence
was in cases with feline leukemia virus (FeLV) [85]. Feline
infections with this gammaretrovirus generally result in a mild
viremia with high titers of neutralizing antibodies, while about
a third of cases fail to mount an effective humoral response
and succumb to complications arising from virally induced
immunosuppression. For this purpose, FeLV has been
suggested to serve as a model system for human infections
with HIV (human immunodeficiency virus-1) [86].
Since immunosuppression in FeLV cases has been asso-
ciated with reduced PMN function, Wardini et al. addressed
this issue in more detail, including an analysis of the host
NETotic response [85]. Their results indicated that feline
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PMNs underwent NETosis when exposed to Leishmania
promastigotes. The degree of NETosis was elevated in
asymptomatic FeLV-infected cats and was dramatically ele-
vated in symptomatic FeLV-infected cats. These data sug-
gest that FeLValters the NETotic response of PMNs and that
the measure of this index can be used as a prognostic marker
of disease progression [85]. It is currently unclear how
virally enhanced NETosis can lead to immunosuppression,
but it is possible that overt stimulation of the NETotic
response may lead to PMN depletion and exhaustion of
the underlying progenitors.
Downmodulation of NETosis by HIV: paving the way
for secondary infections?
In a recent report by Saitoh et al., it was shown that HIV
triggers NETosis via a process that involved the recognition
of viral nucleic acids via engagement with TLR7 and TLR8
[87, 88]. A unique feature of this study is that by the use of
super-resolution structured illumination microscopy (SR-
SIM) [89], they were able to directly visualize individual
HIV virions trapped in the NET lattice. They were, further-
more, able to determine that PMN NETs not only
immobilized HIV virions but were able to reduce their
infectivity via the action of MPO (myeloperoxidase) and
α-defensin. This appears to involve intact NETs, as it was
reduced if the DNA lattice backbone was digested by DN-
Ase treatment. These data, therefore, suggest that PMN
NETs could play an important part in the initial innate
response to HIV infection by facilitating viral trapping,
inactivation, and clearance.
Unfortunately, HIV is a devious pathogen and will use a
whole range of mechanisms to modulate and manage the
host immune system in order to foster its propagation. One
such means is by binding to Dendritic Cell-Specific
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Fig. 3 Immunothrombosis supports the innate immune defense
against pathogens. Immunothrombosis involves an intricate interplay
between complement, coagulation, and innate immune effector cells.
By assembly of a thrombus around the pathogenic microorganisms,
their systemic spread is prevented and the damage to the host is
minimized. PRR pattern recognition receptor, TLR toll-like receptor,
TF tissue factor, vWF von Willebrand factor, NE neutrophil elastase,
PMN polymorphonuclear neutrophil. Adapted and modified from
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Intercellular adhesion molecule-3-Grabbing Non-integrin
(DC-SIGN), also termed CD209. This mannose-binding C-
type lectin receptor can serve as an anchor for HIV virions
on dendritic cells (DC) and, thereby, promote the efficient
infection of CD4+ T cells that engage with this antigen-
presenting cell [90].
By examining this interaction, it was determined that the
binding of HIV virions to isolated DCs leads to the produc-
tion of a factor that inhibited PMN NETosis. This feature
was dependent on the gp120 membrane glycoprotein of
HIV, as it could be mimicked by addition of recombinant
gp120 to DCs. (Fig. 4). Further analysis indicated that the
factor released by gp120/CD-SIGN-primed DCs was the
immune-modulating cytokine IL-10. In this manner, addi-
tion of recombinant IL-10 to PMN cultures lead to a reduc-
tion in their NETotic capability and prevented these cells
from effectively engaging and debilitating HIV.
Individuals with HIV are highly prone to secondary in-
fections, especially those of the pulmonary system with
pathogens such as M. tuberculosis or S. pneumoniae, which
result in high degrees of mortality. Consequently, these
findings have considerable implications for anti-HIV thera-
peutic strategies in order to counter AIDS-associated neu-
tropenia and to ensure an effective innate immune response.
In this context, it is worth noting that coinfection with M.
tuberculosis bacilli can accelerate AIDS progression, since
this bacterium can promote the replication of HIV and
infection of CD4+ T cells [91].
Malaria: a possible autoimmune component?
A number of previous studies have shown that PMNs can
generate NETs against multicellular eukaryotic parasites,
including the use of Leishmania promastigotes in the study
of NETosis in FeLV-infected cats [85, 92]. In human pathol-
ogy, among the most important parasites are Plasmodium
falciparum and Plasmodium vivax, the agents responsible
for malaria with lethal outcome [93].
In pediatric patients infected with P. falciparum, Baker et
al. made the striking observation that NETting PMNs could be
readily detected directly in blood smears [94]. An examination
of total PMNs in the smears indicated that P. falciparum
infection was associated with a high proportion of segmented
PMN, which decreased following treatment with Fansidar®
(sulphadoxine–pyrimethamine). Of interest is that drug thera-
py leads to an increase in immature PMNs (metamyelocytes)
and a significant decrease in bands. The degree of NETosis did
DC
CD209
gp120
IL10
PMN
TLR7
TLR8
ROS
NETing PMN
HIV
ROS
Fig. 4 HIV downmodulates
NETosis via dendritic cells.
HIV triggers NETosis via a
process that involves TLR7 and
TLR8, trapping individual HIV
virions in the NET lattice. Viral
binding to CD209 anchors the
virions on dendritic cells (DC),
thereby promoting the efficient
infection of CD4+ T cells. The
gp120/CD209-primed DC cells
produce the immune-
modulating cytokine IL-10,
leading to a reduction in
NETotic capability, thereby
preventing PMN from
effectively engaging and
eliminating HIV
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not appear to be significantly influenced by therapy, although
there was an increase in the number of cases observed post
therapy (100 vs. 86 %). NETosis did, however, appear to
correlate with plasma TNFα levels, indicating that a strong
proinflammatory component was driving this response.
Of additional interest is that the occurrence of NETs
appeared to correlate with the presence of antinuclear anti-
bodies (ANA), with high levels of antibodies reactive with
dsDNA, predictive of autoimmunity. Such autoantibodies
could contribute to other malaria-related features such as
renal dysfunction and uremia. These data may provide ad-
ditional insight into the possible link between lupus suscep-
tibility genetic loci and resistance to malaria [95], or into the
possible mechanism of action of antimalarial drugs such as
chloroquine and hydroxychloroquine used for the treatment
of autoimmune conditions [96].
Influence of the host: pulmonary system
The ability of PMNs to form NETs is not only dependent on
the external stimulus but also depends on the physiological
status of the PMNs and the host microenvironment. One of
the best characterized host microenvironments is the pulmo-
nary system.
The alveolar epithelium synthesizes proteins such as the
surfactant protein A and D (SP-A, SP-D), members of the
collectin family of PPRs, which bind carbohydrate moieties
on pulmonary pathogens such as M. tuberculosis or S.
pneumonia as well as fungi. Absence of these factors in
genetically manipulated knockout mice diminished their
capability to clear P. aeruginosa infections [97]. That these
factors can interact with members of the innate immune
system to promote an antibacterial response is underscored
by the recent finding that SP-D can bind pathogens as well
as NETs in order to augment NET-mediated bacterial trap-
ping and eradication [98] (Fig. 5).
On the other hand, numerous observations suggest that
aberrant NETosis can lead to damage of the fragile alveoli
[81]. Such NETosis-associated damage may be triggered by
host trauma in conditions such as transfusion-related acute
lung injury (TRALI) following blood transfusions [99, 100]
or be the result of viral infection [82]. Indeed, under such
conditions of influenza infection, NETs appear to be inca-
pable of clearing any secondary infections with pneumococ-
ci but rather contribute to increasingly compromised lung
function [101].
It has, furthermore, been shown that an underlying dis-
turbance of the alveolar tissue, as in the instance in cystic
fibrosis (CF), can trigger NETosis, thereby contributing to
the bronchial pool of cell-free DNA [102]. In order to clear
this thick and sticky sputum, exogenous DNAse is used as a
therapeutic agent [102]. In examining the contribution of
PMN NETs to this phenomenon, it was observed that neu-
trophil elastase (NE) promoted the solubilisation of CF
sputum by assisting with the degradation of histones.
This PMN-derived enzyme, however, does not only play
a role in the clearance of excess NET debris but also, in
combination with protease 3 and cathepsin G, may play a
significant role in the damage caused to the underlying
alveolar epithelium [103]. In a further study using atom-
ic force and scanning electron microscopy, it was deter-
mined that the major portion of DNA in CF sputum
resulted from excessive NETosis [104]. Consequently, it
will be necessary to refocus therapeutic strategies to
tackle NETs as a whole rather than focus on the sole
dissolution of individual DNA fibers.
The occurrence of this highly gelatinous mucous in the
lungs may, however, render this microenvironment more
amenable to infections, such as those with P. aeruginosa,
which frequently occur in patients with CF [105]. In this
scenario, it appears that the highly dense DNA-based bio-
film permits P. aeruginosa to adopt a NET resistance phe-
notype, thereby evading efficacious removal by this arm of
the innate immune system. This phenomenon appears to be
specific for P. aeruginosa isolates from affected CF lungs,
as PMN isolated from CF patients were quite capable of
generating NETs against normal P. aeruginosa isolates and
killing these efficiently [105].
Influence of the host: pregnancy
Pregnancy poses a unique immune challenge as the mother
has to maintain an effective immune response against path-
ogens deleterious to her own health and yet not mount a
response that be deleterious to her unborn child [106].
Although most studies have largely focussed on how the
maternal T cell response is modulated to avoid rejection of
the semiallogeneic components of her fetus via regulatory T
cells [107] or a shift in T cell cytokine profiles (Th1 vs. Th2)
[108], it has become evident that pregnancy involves con-
siderable changes in the activity of the innate immune
system, specifically in that of neutrophils [109]. In gen-
eral, pregnancy is associated with neutrophil leucoytosis,
with numbers increasing from the second month of preg-
nancy and plateauing at term. Neutrophil action in the
reproductive cycle is quite diverse and may range from
the trapping and elimination of excess spermatozoa di-
rectly in the reproductive tract during fertilization, the
rendering of the myometrium more receptive to implan-
tation, or the contribution to the etiology of preeclampsia
via overt NETosis [109, 110].
The modulation of the immune system, both innate and
adaptive, during pregnancy may, however, be more exten-
sive that initially thought. In this manner, due to elevated
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oestrogen levels, the upper respiratory tract in pregnancy
is associated with increased mucous secretion, capillary
congestion, and fragility [81]. This may render pregnant
women more susceptible to airborne noxins or pathogens.
Such respiratory infections can have severe consequences
for the fetus, as they can lead to secondary placental
infections, which may even result in stillbirth or septic
abortion [111].
While it is well appreciated that prenatal exposure to
maternal smoking or airborne particulate matter is associat-
ed with higher rates of pediatric asthma [112], new data
indicate that these events may debilitate the neonatal im-
mune response [113], rendering the developing child more
susceptible to infections [114].
With regard to the pathogenic agents covered in this
review in the context of neutrophil interactions, two points
are worth noting:
1. Low maternal and neonatal neutrophil counts are asso-
ciated with an increased risk of HIV transmission in
utero in African populations [115]. This suggests that
anti-HIV therapy in women with low neutrophil counts
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Fig. 5 NETosis—modulation by the respiratory system. The response
of the respiratory system to infection is complex involving chemokine
recruitment of neutrophils and monocytes into the lumen of the alveoli.
The NETotic release of cytotoxic DNA–protein complexes with NE,
MPO, LL37, and other neutrophil proteases increases mucus viscosity
and contributes to lung epithelial damage, thereby perpetuating a
vicious cycle of injury and inflammation. Innate immune surfactant
proteins (also termed collectins) contribute in maintaining the lungs'
homeostasis with minimal inflammation. NETs are removed by DN-
Ase degradation and macrophage ingestion. A delicate equilibrium
between NETosis and NET clearance is fundamental for the successful
combating of infectious agents with minimum tissue damage. NE
neutrophil elastase, MPO myeloperoxidase, LL37 cathelicidin, SP-A
surfactant protein A, SP-D surfactant protein D, PMN polymorphonu-
clear neutrophil, Mφ macrophages. Adapted and modified from Chen
et al. [81]
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may need to be started earlier in pregnancy to prevent
viral transmission to the fetus.
2. Pregnant women are more susceptible to infections with
influenza, resulting in high degrees of maternal or fetal
morbidity and mortality [116].
3. In affected populations, pregnant women generally have
a higher risk for malaria than nonpregnant women
[117]. Since the malaria parasite is sequestered to the
placenta, this leads to severe complications such as fetal
growth restriction and preterm delivery [117, 118].
It is not clear why pregnant women should be more
susceptible to malaria infection, especially if they are
primigravid, but it may be linked to a reduction in neutrophil
counts [119] and dysfunction of residual neutrophils due to
impaired NADPH oxidase activity [120].
These findings suggest that pregnant women should
be regarded as a separate entity at high risk for infec-
tion with a diverse array of pathogens. This may result
from an altered immune response and, consequently,
implies that pregnant women will require tailored ther-
apeutic strategies.
Discussion and conclusions
In this review, the emphasis has been placed on mecha-
nisms used by pathogenic microorganisms to evade en-
trapment and killing by PMN NETs. These range from
the expression of DNAse molecules that degrade the
nucleic acid lattice backbone [10] to the induction of
immune-modulatory molecules such as IL-10 that damp-
en the NETotic response of PMN. The latter is employed
by both HIV [88] or Sias-coated P. aeruginosa bacteria
[14]. In the context of HIV, it is possible that IL-10-
mediated dampening of the innate immune response may
contribute to the secondary infection of affected individ-
uals with tuberculosis or pneumococci.
By studying such interactions in more detail, it may
not only be possible to devise strategies to optimize the
host immune response but also develop therapies to
counter pathologies associated with overt NETosis. In
this manner, by antagonising the effect of IL-10 in cases
with AIDS, it may be possible to reduce concomitant
secondary infections. On the other hand, the use of IL-
10 may be of interest in autoimmune conditions associ-
ated with increased NETosis such as systemic lupus
erythematosus [121, 122].
In this regard, it is ironic that the first therapy used to
alleviate and facilitate clearing of the dense mucus, which
largely consists of NETs, from the lungs of CF patients was
by the application of rhDNAse [123], thereby mimicking a
strategy first explored by streptococcal bacteria [10, 11].
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